Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients
- PMID: 36385679
- DOI: 10.1093/jjco/hyac169
Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients
Abstract
Objective: Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to assess conditional survival in stages I-III early onset colorectal cancer patients and to create nomograms predicting the conditional overall survival and cancer-specific survival after surgery.
Methods: A total of 7058 patients who underwent surgical resection of early onset colorectal cancer were identified from surveillance, epidemiology and end results database. The formula used for conditional survival calculation was conditional survival(x|y) = S(x + y)/S(x), where S(x) represents the survival at x years. Conditional survival nomograms were then developed to predict the 5-year conditional overall survival and cancer-specific survival.
Results: The 5-year overall survival and cancer-specific survival after surgery increases gradually with additional survival time. Race, tumour site, grade, histology, T stage, N stage, lymph node ratio, preoperative carcinoma embryonic antigen level and perineural invasion status were independent predictors of cancer-specific survival, while age and sex were another two independent risk factors for overall survival. The nomograms based on these factors were successfully developed to predict 5-year overall survival and cancer-specific survival given 1-4 years already survived.
Conclusion: The probability of achieving postoperative 5-year overall survival and cancer-specific survival for early onset colorectal cancer increases gradually with additional time survived. The developed nomograms are fairly valuable and informative in facilitating clinical treatment and follow-up schemes.
Keywords: cancer-specific survival; conditional survival; early onset colorectal cancer; nomogram; overall survival.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Individualized prediction of conditional survival for colorectal signet-ring cell carcinoma patients.Ann Med Surg (Lond). 2024 Mar 25;86(5):2524-2530. doi: 10.1097/MS9.0000000000001982. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694354 Free PMC article.
-
Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.Eur J Surg Oncol. 2021 Dec;47(12):3175-3181. doi: 10.1016/j.ejso.2021.06.010. Epub 2021 Jun 6. Eur J Surg Oncol. 2021. PMID: 34120806
-
Nomograms to predict survival after colorectal cancer resection without preoperative therapy.BMC Cancer. 2016 Aug 19;16(1):658. doi: 10.1186/s12885-016-2684-4. BMC Cancer. 2016. PMID: 27553083 Free PMC article.
-
Conditional Cancer-Specific Survival for Inflammatory Breast Cancer: Analysis of SEER, 2010 to 2016.Clin Breast Cancer. 2023 Aug;23(6):628-639.e2. doi: 10.1016/j.clbc.2023.05.005. Epub 2023 May 19. Clin Breast Cancer. 2023. PMID: 37286434
-
Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis.Updates Surg. 2024 Oct;76(6):2163-2171. doi: 10.1007/s13304-024-01869-5. Epub 2024 May 10. Updates Surg. 2024. PMID: 38728004
Cited by
-
Development and validation of cancer-specific survival prediction nomogram for patients with T4 stage colon cancer after surgical resection: a population-based study.Int J Colorectal Dis. 2025 Mar 18;40(1):72. doi: 10.1007/s00384-025-04856-3. Int J Colorectal Dis. 2025. PMID: 40102264 Free PMC article.
-
A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic colorectal cancer.Discov Oncol. 2024 May 21;15(1):179. doi: 10.1007/s12672-024-01042-9. Discov Oncol. 2024. PMID: 38772985 Free PMC article.
-
Construction and validation of a nomogram for predicting overall survival of patients with stage III/IV early-onset colorectal cancer.Front Oncol. 2024 Apr 10;14:1332499. doi: 10.3389/fonc.2024.1332499. eCollection 2024. Front Oncol. 2024. PMID: 38660128 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical